CGAS and Parkinson disease: In Parkinson’s disease (PD), mouse models of α-synucleinopathies, which mimic the neuropathology of PD, show specific activation of cGAS-STING in the nigrostriatal regions, accompanied by elevated cytokine levels and enhanced neuroinflammation [67].